Follow us:

REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

News

Workshop presenting

Pilar M. Muñoz (CITA) participates as invited speaker at the Annual Workshop of the European Reference Laboratories for Brucellosis (EURL for Brucellosis)

Dr. Pilar M. Muñoz participated as an invited speaker at the Annual Workshop of the European Union Reference Laboratory (EURL) for Brucellosis, held at the headquarters of the Agence Nationale de Sécurité Sanitaire (ANSES) in Maisons-Alfort, France. The event brought together around 50 scientists and technical experts from brucellosis reference laboratories across Europe.

In her presentation, entitled “Brucellin for porcine brucellosis specific diagnosis: novel antigen from a genetically modified strain and advances toward synthetic brucellin”, Dr. Muñoz presented the latest advances achieved within the REPRODIVAC project in the development of new diagnostic strategies for porcine brucellosis, focusing on the use of the brucellin skin test.

Her talk highlighted the progress made towards the production of a synthetic brucellin, one of the project’s key objectives, through the application of state-of-the-art techniques developed at ENEA (Italy). This innovative approach aims to improve the specificity and reproducibility of diagnostic tools, contributing to a more effective control and eradication of porcine brucellosis in Europe.

The participation of REPRODIVAC in this workshop reinforces international scientific collaboration and underscores the relevance of the project’s research in advancing diagnostic methods for animal diseases of major health and economic importance.

EURL Brucellosis workshop fr
EURL Brucellosis workshop France

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.
Feedback